Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 28;15(11):e49546.
doi: 10.7759/cureus.49546. eCollection 2023 Nov.

The Expression of Mucin-4 (MUC4) in Sarcomas Apart From Sclerosing Epithelioid Fibrosarcoma and Low-Grade Fibromyxoid Sarcoma

Affiliations

The Expression of Mucin-4 (MUC4) in Sarcomas Apart From Sclerosing Epithelioid Fibrosarcoma and Low-Grade Fibromyxoid Sarcoma

Usman Hassan et al. Cureus. .

Abstract

Background Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (SEF) are two rare but aggressive soft tissue sarcomas that can be difficult to distinguish due to histopathological similarities. The present study examines the diagnostic capacities of mucin-4 (MUC4), a transmembrane mucin, in identifying different types of sarcomas and broadens its evaluation to include a wide range of sarcomas. Methods Immunohistochemical (IHC) examination of tissue samples from various sarcomas was performed using a mouse anti-MUC4 monoclonal antibody. IHC was conducted on 4-mm thick formalin-fixed paraffin-embedded tissue sections after pressure cooker antigen retrieval with a mouse anti-MUC4 monoclonal antibody. Results MUC4 was shown to be highly expressed in SEF (n=13) and LGFMS (n=10), while focal positivity in synovial sarcoma (n=1). Other sarcomas, such as malignant peripheral nerve sheath tumors, fibrosarcoma, leiomyosarcoma, liposarcoma, and myxofibrosarcoma, exhibited no expression (n=0). These findings are consistent with previous research and support MUC4 specificity as a SEF and LGFMS marker. This study provides information on the diagnostic efficacy of MUC4, particularly in the context of certain subtypes. It not only helps our understanding of these unique instances, but it also provides context for histopathological and IHC findings in soft tissue sarcoma. Furthermore, this study investigates the influence of age and gender on MUC4 expression in a range of sarcomas, which was typically understudied in the literature and found no relation with expression of MUC4. Conclusion In conclusion, this study adds to our understanding of soft tissue sarcomas by emphasizing the crucial role of MUC4 in certain sarcoma subtypes while acknowledging the complex variety of the sarcoma landscape. Further research is needed to understand the molecular mechanism that governs marker expression patterns, as well as the therapeutic implications.

Keywords: lgfms; low-grade fibromyxoid sarcoma; muc4; sclerosing epithelioid fibrosarcoma; sef; synovial sarcoma.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Histopathological characteristics of fibrosarcoma involving the thigh; an infiltrative tumor composed of spindle cells with moderate to marked atypia (40x)
Figure 2
Figure 2. Fibrosarcoma involving thigh: No expression of MUC4 (40x)
MUC4: Mucin-4
Figure 3
Figure 3. Liposarcoma involving retroperitoneum, showing myxoid background composed of sheets of lipoblasts and giant cells (20x)
Figure 4
Figure 4. Liposarcoma of retroperitoneum showing positive expression for MDM2 (20x)
MDM2: Murine double minute 2
Figure 5
Figure 5. Liposarcoma of retroperitoneum showing positive expression for p16 (40x)
p16 (also known as p16INK4a, cyclin-dependent kinase inhibitor 2A, CKN2A)
Figure 6
Figure 6. No expression of MUC4 in reteroperitoneal liposarcoma (40x)
MUC4: Mucin-4
Figure 7
Figure 7. Malignant peripheral nerve sheath tumor of the calf: an infiltrative tumor composed of spindle cells with pleomorphic nuclei arranged in whorling and diffuse patterns (40x)
Figure 8
Figure 8. No expression of MUC4 in MPNST of lower limb (calf) (40x)
MUC4: Mucin-4, MPNST: Malignant peripheral nerve sheath tumor
Figure 9
Figure 9. MPNST of the lower limb, showing positive expression of S-100 protein (40x)
MPNST: Malignant peripheral nerve sheath tumor S-100 protein (solubility in 100%-saturated solution with ammonium sulphate at neutral pH)
Figure 10
Figure 10. Myxofibrosarcoma involving chest wall: an infiltrative tumor arranged in a lobular configuration having fibromyxoid stroma and arcuate-like vascular pattern (40x)
Figure 11
Figure 11. No expression of MUC4 in myxofibrosarcoma of the chest wall (40x)
MUC4: Mucin-4
Figure 12
Figure 12. Synovial sarcoma of the forearm: an infiltrative tumor composed of spindle cells arranged in fascicles and background showing hemangiopericytoma-like vascular pattern (40x)
Figure 13
Figure 13. Upper limb synovial sarcoma showing strong positive expression of TLE1 (40x)
TLE1: Transducin-like enhancer protein 1
Figure 14
Figure 14. Upper limb synovial sarcoma showing focal positivity for MUC4 (40x)
MUC4: Mucin-4
Figure 15
Figure 15. Leiomyosarcoma of lower limb; fascicles of smooth muscle fibers displaying a moderate degree of nuclear atypia and pleomorphism (40x)
Figure 16
Figure 16. Leiomyosarcoma showing positive expression of desmin in smooth muscle fibers (40x)
Figure 17
Figure 17. Leiomyosarcoma: Positive expression for smooth muscle fibers for Caldesmon (10x)
Figure 18
Figure 18. Leiomyosarcoma: No expression of MUC4 in the smooth muscle fibers (10x)
MUC4: Mucin-4
Figure 19
Figure 19. Sclerosing epithelioid fibrosarcoma involving the trunk, composed of round to polygonal epithelioid cells with sparse cytoplasm, round-to-oval nuclei, and inconspicuous nucleoli (20x)
Figure 20
Figure 20. Low-grade fibromyxoid sarcoma: An infiltrative tumor of the upper limb showing moderately cellular bland-looking fusiform spindle cell with abrupt transition to myxoid areas (arrowhead) (40x)
Figure 21
Figure 21. Positive expression of MUC4 in SEF of the trunk (20x)
MUC4: Mucin-4, SEF: Sclerosing epithelioid fibrosarcoma
Figure 22
Figure 22. Strong positive expression of MUC4 in LGFMS (40x)
MUC4: Mucin-4, LGFMS: Low-grade fibromyxoid sarcoma

References

    1. Sclerosing epithelioid fibrosarcoma of the thoracic vertebrae: an fairly unusual case report with a short review of literature. Wei C, Ma Y, Wu D, Chen X, Li C, Chen J, Zhou S. Front Med (Lausanne) 2022;9:833–864. - PMC - PubMed
    1. Low-grade fibromyxoid sarcoma in the middle ear as a rare location: a case report. Guo Y, Hao Y, Guan G. Transl Pediatr. 2022;11:1034–1039. - PMC - PubMed
    1. Low-grade fibromyxoid sarcoma: a clinicopathologic and molecular study of 10 genetically confirmed cases. Li M, Chen H, Shi D, Chen M, Zhang Z, Zhang H. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963072/#:~:text=LGFMS%20is... Int J Clin Exp Pathol. 2018;11:5860–5868. - PMC - PubMed
    1. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Doyle LA, Wang WL, Dal Cin P, et al. Am J Surg Pathol. 2012;36:1444–1451. - PubMed
    1. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Doyle LA, Möller E, Dal Cin P, Fletcher CD, Mertens F, Hornick JL. Am J Surg Pathol. 2011;35:733–741. - PubMed

LinkOut - more resources